公司概覽
業務類別 Capital Markets
業務概覽 Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. HSI aims to provide capital-efficient and productive access to the HYPE token for U.S. and institutional investors, generating compounding shareholder returns that individual holders may not be able to replicate through staking, yield optimization, and active ecosystem engagement. HSI is positioned to become the largest HYPE-focused digital asset treasury vehicle capitalizing on Hyperliquid's rapid growth and providing exposure to one of the largest and fastest growing revenue pools in digital assets.
公司地址 477 Madison Avenue, 22nd Floor, New York, NY, USA, 10022
電話號碼 +1 212 883-4330
傳真號碼 --
公司網頁
員工數量 --
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Jeroen Nieuwkoop Chief Operating Officer -- 03/12/2025
Mr. David Schamis President and Chief Executive Officer -- 03/12/2025
Mr. Brett Beldner Chief Financial Officer -- 03/12/2025
 
董事會成員
董事會 職務 更新日期
Mr. Eric S. Rosengren Independent Director 03/12/2025
Mr. Larry Leibowitz Independent Director 03/12/2025
Mr. Albert D. Dyrness Independent Director 03/12/2025
Mr. Bob Diamond Chairman of the Board 03/12/2025
Mr. Thomas C. King Independent Director 03/12/2025
Mr. Jeffrey M. Tuder Director 03/12/2025
Mr. Nailesh Bhatt Independent Director 03/12/2025
 
所屬ETF (更新日期: 02/05/2026 03:25)
代號 名稱 佔比% 持有日期
XBIState Street® SPDR® S&P® Biotech ETF2.24%29/04/2026
ITOTiShares Core S&P Total US Stock Mkt ETF0.14%29/04/2026
LABUDirexion Daily S&P Biotech Bull 3X ETF0.11%29/04/2026
NODEVanEck Onchain Economy ETF0.02%25/04/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.